Skip to main content

Welcome to our new website. We’re still fine-tuning things. If you experience any issues or would like to provide feedback, please contact us.

Thomas
V.
Inglesby
,
MD

Director, Center for Health Security
Professor

Contact Info

621 E. Pratt Street, Suite 210
Baltimore
Maryland
21202
US        
443-573-3305

Research Interests

Public Health Preparedness; Biosecurity; Health Security; Emerging Infectious Diseases; Resilience; Biological Threats; Dual Use; Science Policy; Public Policy; Laboratory Safety; Healthcare Preparedness; Preparedness; Global Health Security
Experiences & Accomplishments
Education
MD
Columbia University
1992
BA
Georgetown University
1988
Overview
Dr. Inglesby is a Professor with joint appointments at the Johns Hopkins Bloomberg School of Public Health and in the Johns Hopkins School of Medicine. Until January 16, 2017, he was Professor in the University of Pittsburgh’s School of Medicine, Department of Medicine, in the Division of Infectious Diseases with a secondary appointment as Professor at the University of Pittsburgh Graduate School of Public Health. He joined the faculty of the University of Pittsburgh Schools of Medicine and Public Health in 2003 as Associate Professor. Prior to that, he was Assistant Professor in the Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Diseases. Dr. Inglesby is also the Director of the Johns Hopkins Center for Health Security, serving in that role since 2016. The Center was originally founded by DA Henderson in 1998 at the Johns Hopkins School of Public Health. The mission of the Center is to protect people from epidemics and disasters through independent research, policy analysis, and program assessment. He and his Center colleagues study the organizations, policies, systems and tools intended to prevent and respond to epidemics and other major public health crises. He directs the group of 20 full-time and 8 part-time scholars, research staff, and editorial and administrative staff at the Center. Dr. Inglesby received his BA from Georgetown University and his MD from Columbia University College of Physicians and Surgeons. He completed his Internal Medicine residency and Infectious Diseases Fellowship at Johns Hopkins University Hospital. He was Assistant Chief of Service in the Johns Hopkins Department of Medicine from 1996-1997.
Select Publications
Selected publications intended to represent different areas of my research and policy interests.
  • Schoch-Spana M, Cicero A, Adalja A, Gronvall G, Kirk Sell T, Meyer D, Nuzzo J, Ravi S, Shearer M, Toner E, Watson C, Watson M, Inglesby TV. Global Catastrophic Biological Risks: Toward a Working Definition. Health Security. 2017 July, in press.
  • Adalja A, Toner E, Inglesby TV. Clinical Management of Potential Bioterrorism-Related Conditions. New England Journal of Medicine 2015 Mar 5; 372:954-962.
  • Lipsitch, M, Inglesby TV. Moratorium on Research Intended to Create Novel Potential Pandemic Pathogens. Mbio 2014 Dec 12;5(6). pii: e02366-14. doi: 10.1128/mBio.02366-14.
  • Nuzzo J, Cicero A, Waldhorn R, Inglesby TV. Travel bans will increase the damage wrought by Ebola. Biosecur Bioterror 2014;12(6):306-309. doi: 10.1089/bsp.2014.1030.
  • Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MA, Eitzen E, et.al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287(17):2236-2252.
Projects
Development of a Model of Community Functioning during Disasters: The CoPE-WELL Model
Emerging Leaders in Biosecurity Initiative
Global Health Security Agenda Ministerial Meeting in Uganda
Global Health Security Index
Harnessing Technology to Address Global Catastrophic Biological Risks
Iraq Implementers Conference
International Biosafety Norms
Outbreak Observatory
PASCC US - India Biosecurity Dialogue
Multilateral Biosecurity Dialogue – Indonesia, Malaysia, Singapore and US
Persuasive Communications about Risks from and Response to Zika
Red Teaming Global Catastrophic Biological Risks
A Framework to Analyze the Pandemic Potential of Pathogens
Mobilizing Allies for Global Catastrophic Biological Risks